Targato, G.; Bortot, L.; Dri, A.; Bonotto, M.; Minisini, A.M.; Fasola, G.; Mansutti, M.
CDK4/6 Inhibitors as Upfront Treatment in a Patient with Breast Cancer Presenting with a Clinical Critic Situation: A Case Report and Review of the Literature. Curr. Oncol. 2022, 29, 9630-9639.
https://doi.org/10.3390/curroncol29120756
AMA Style
Targato G, Bortot L, Dri A, Bonotto M, Minisini AM, Fasola G, Mansutti M.
CDK4/6 Inhibitors as Upfront Treatment in a Patient with Breast Cancer Presenting with a Clinical Critic Situation: A Case Report and Review of the Literature. Current Oncology. 2022; 29(12):9630-9639.
https://doi.org/10.3390/curroncol29120756
Chicago/Turabian Style
Targato, Giada, Lucia Bortot, Arianna Dri, Marta Bonotto, Alessandro Marco Minisini, Gianpiero Fasola, and Mauro Mansutti.
2022. "CDK4/6 Inhibitors as Upfront Treatment in a Patient with Breast Cancer Presenting with a Clinical Critic Situation: A Case Report and Review of the Literature" Current Oncology 29, no. 12: 9630-9639.
https://doi.org/10.3390/curroncol29120756
APA Style
Targato, G., Bortot, L., Dri, A., Bonotto, M., Minisini, A. M., Fasola, G., & Mansutti, M.
(2022). CDK4/6 Inhibitors as Upfront Treatment in a Patient with Breast Cancer Presenting with a Clinical Critic Situation: A Case Report and Review of the Literature. Current Oncology, 29(12), 9630-9639.
https://doi.org/10.3390/curroncol29120756